Aerovate Therapeutics, Inc.·4

Mar 23, 7:47 AM ET

Verwijs Marinus 4

4 · Aerovate Therapeutics, Inc. · Filed Mar 23, 2022

Insider Transaction Report

Form 4
Period: 2022-03-21
Verwijs Marinus
Senior Vice President, CMC
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-21+90,00090,000 total
    Exercise: $14.59Exp: 2032-03-20Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest and become exercisable on March 21, 2023, with the remainder vesting in 36 substantially equal monthly installments.

Documents

1 file
  • 4
    ownership.xmlPrimary